Instrumento Inactivo

Otros idiomas BioSyent Inc. Other OTC

Acciones

Canadian Currency	31/05	FA
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	17/05
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024	17/05
BioSyent To Present At LD Micro New York Investor Conference	01/04
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
BioSyent Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
BioSyent Inc. Seeks Acquisitions	13/03
Transcript : BioSyent Inc., Q4 2023 Earnings Call, Mar 13, 2024	13/03
Canadian Currency	28/02	FA
BioSyent Inc. Declares First Quarter 2024 Dividend, Payable on March 15, 2024	06/02
BioSyent Inc. (TSXV:RX) announces an Equity Buyback for 650,000 shares, representing 5.53% of its issued share capital.	13/12
BioSyent Inc. authorizes a Buyback Plan.	13/12
Canadian Currency	29/11	FA
Biosyent Reports Q3 2023 Results	16/11
BioSyent Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11
Transcript : BioSyent Inc., Q3 2023 Pre Recorded Earnings Call, Nov 16, 2023	16/11
BioSyent Inc. Declares Fourth Quarter 2023 Dividend, Payable on December 15, 2023	15/11
Canadian Currency	30/08/23	FA
BioSyent Posts Higher Q2 Net Income, Revenue YOY	22/08/23
BioSyent Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	22/08/23

No hay resultados para esta búsqueda